University of Southern California, JD, (Order of the Coif), 1988 University of California, Los Angeles, PhD, (Postdoctoral Fellowship (1984-1985) National Institutes of Health), 1984 University of California, Los Angeles, MS, 1979 University of Kansas, BS, 1977
Mary Andrues’ practice focuses on white collar criminal defense; internal corporate investigations; anti-corruption and bribery compliance, defense and investigations; international and domestic export compliance and enforcement; health care fraud and abuse; and complex commercial litigation. With more than 20 years of trial experience and as a former federal prosecutor, Mary understands the anatomy of a government investigation and is sensitive to the impact government investigations have on corporate clients. She has extensive experience defending complex white collar criminal cases, particularly in matters involving the Foreign Corrupt Practices Act, export enforcement, including the Arms Export Control Act, International Traffic in Arms Regulations, International Emergency Economic Powers Act, Export Administration Act, and health care fraud and abuse. She also has successfully represented clients in cases involving government contract and procurement fraud, political corruption, and improper political contributions.
Mary was recognized by Best Lawyers in America 2013 for her achievements in Criminal Defense: White Collar, and has been recognized by the Southern California edition of Super Lawyer as a 2012 Top Women Attorney. She was also chosen as the “Pro Bono Attorney of the Year” by the University of Southern California Public Interest Law Foundation in 2009.
Mary’s published works include, among others: • “False Claims and ITAR - A Lethal Combination,” Law360; February 2011 • “ITAR Enforcement Update and Q&A” and “What to Do if You Suspect or Discover a Violation: When and How to Investigate, Prepare a Voluntary Disclosure and Implement Remedial Measures,” American Conference Institute, ITAR Boot Camp; February 2011 • “Increasing Government Scrutiny of Pharmaceutical Executives,” Arent Fox LLP Client Alerts; December 2010, co-author • “FCPA Shouldn’t Be Platform For Derivative Litigation,” Law360; November 2010 • “Fueling FCPA Enforcement,” Law360; October 2010 • White Collar Defense Roundtable, California Lawyer; July 2010 • “What to Do When Agents Show Up At Your Door,” American Conference Institute, Export Enforcement & Investigations; January 2010
Prior to joining Arent Fox, Mary was an Assistant US Attorney in the US Attorney's Office in the Central District of California, where she served as the Chief of the Public Corruption and Civil Rights Section; and Deputy Chief of the Public Corruption and Government Fraud Section. She also served as Health Care Fraud Coordinator and as a member of the US Department of Justice, Attorney General's Advisory Committee, Health Care Fraud Subcommittee.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.